Its potential use in AD could be based on several mechanisms of action, as MH has proven to decrease the formation of Aβ plaques in mice models [6,7], also reducing hyperphosphorylated tau protein levels in neurons at concentrations around 1–2 μM [8,9]. This evidence concerns the gene MAPT and Alzheimer disease.